Expression and cisplatin sensitivity of copper-transporting P-type adenosine triphosphatase (ATP7B) in human solid carcinoma cell lines - PubMed (original) (raw)
. 2001 Nov-Dec;8(6):1285-7.
doi: 10.3892/or.8.6.1285.
Affiliations
- PMID: 11605050
- DOI: 10.3892/or.8.6.1285
Expression and cisplatin sensitivity of copper-transporting P-type adenosine triphosphatase (ATP7B) in human solid carcinoma cell lines
K Nakayama et al. Oncol Rep. 2001 Nov-Dec.
Abstract
One of the most important clinical problems in the treatment of human solid carcinoma is the intrinsic/acquired resistance. Cisplatin is a platinum compound that is one of the most effective agents in clinic. Copper-transporting P-type adenosine triphosphate (ATP7B) has been reported to be associated with cisplatin resistance by the experiment of transfection of full cDNA of ATP7B into KB3-1 lacking ATP7B. We examined the relationship between mRNA expression level of ATP7B and sensitivity to cisplatin in nine human ovarian carcinoma cell lines to extend these findings. mRNA expression level of ATP7B was significantly correlated with cisplatin-sensitivity in nine cell lines, raising the possibility that ATP7B could be a chemoresistance marker in some types of human solid carcinoma.
Similar articles
- Prognostic value of the Cu-transporting ATPase in ovarian carcinoma patients receiving cisplatin-based chemotherapy.
Nakayama K, Kanzaki A, Terada K, Mutoh M, Ogawa K, Sugiyama T, Takenoshita S, Itoh K, Yaegashi N, Miyazaki K, Neamati N, Takebayashi Y. Nakayama K, et al. Clin Cancer Res. 2004 Apr 15;10(8):2804-11. doi: 10.1158/1078-0432.ccr-03-0454. Clin Cancer Res. 2004. PMID: 15102688 - Expression of copper-transporting P-type adenosine triphosphatase (ATP7B) correlates with cisplatin resistance in human non-small cell lung cancer xenografts.
Nakagawa T, Inoue Y, Kodama H, Yamazaki H, Kawai K, Suemizu H, Masuda R, Iwazaki M, Yamada S, Ueyama Y, Inoue H, Nakamura M. Nakagawa T, et al. Oncol Rep. 2008 Aug;20(2):265-70. Oncol Rep. 2008. PMID: 18636185 - Mechanism of tumor resistance to cisplatin mediated by the copper transporter ATP7B.
Dmitriev OY. Dmitriev OY. Biochem Cell Biol. 2011 Apr;89(2):138-47. doi: 10.1139/o10-150. Biochem Cell Biol. 2011. PMID: 21455266 Review. - The roles of copper transporters in cisplatin resistance.
Kuo MT, Chen HH, Song IS, Savaraj N, Ishikawa T. Kuo MT, et al. Cancer Metastasis Rev. 2007 Mar;26(1):71-83. doi: 10.1007/s10555-007-9045-3. Cancer Metastasis Rev. 2007. PMID: 17318448 Review.
Cited by
- KRAS and MAPK1 gene amplification in type II ovarian carcinomas.
Rahman MT, Nakayama K, Rahman M, Katagiri H, Katagiri A, Ishibashi T, Ishikawa M, Sato E, Iida K, Nakayama N, Ishikawa N, Miyazaki K. Rahman MT, et al. Int J Mol Sci. 2013 Jul 2;14(7):13748-62. doi: 10.3390/ijms140713748. Int J Mol Sci. 2013. PMID: 23820584 Free PMC article. - EGFR gene amplification is related to adverse clinical outcomes in cervical squamous cell carcinoma, making the EGFR pathway a novel therapeutic target.
Iida K, Nakayama K, Rahman MT, Rahman M, Ishikawa M, Katagiri A, Yeasmin S, Otsuki Y, Kobayashi H, Nakayama S, Miyazaki K. Iida K, et al. Br J Cancer. 2011 Jul 26;105(3):420-7. doi: 10.1038/bjc.2011.222. Epub 2011 Jul 5. Br J Cancer. 2011. PMID: 21730982 Free PMC article. - Role of copper transporters in resistance to platinating agents.
Rabik CA, Maryon EB, Kasza K, Shafer JT, Bartnik CM, Dolan ME. Rabik CA, et al. Cancer Chemother Pharmacol. 2009 Jun;64(1):133-42. doi: 10.1007/s00280-008-0860-1. Epub 2008 Nov 8. Cancer Chemother Pharmacol. 2009. PMID: 18998134 Free PMC article. - Clinicopathological and biological analysis of PIK3CA mutation and amplification in cervical carcinomas.
Razia S, Nakayama K, Nakamura K, Ishibashi T, Ishikawa M, Minamoto T, Iida K, Otsuki Y, Nakayama S, Ishikawa N, Kyo S. Razia S, et al. Exp Ther Med. 2019 Sep;18(3):2278-2284. doi: 10.3892/etm.2019.7771. Epub 2019 Jul 12. Exp Ther Med. 2019. PMID: 31410178 Free PMC article. - Development of Low-Grade Serous Ovarian Carcinoma from Benign Ovarian Serous Cystadenoma Cells.
Dey P, Nakayama K, Razia S, Ishikawa M, Ishibashi T, Yamashita H, Kanno K, Sato S, Kiyono T, Kyo S. Dey P, et al. Cancers (Basel). 2022 Mar 15;14(6):1506. doi: 10.3390/cancers14061506. Cancers (Basel). 2022. PMID: 35326657 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources